Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on May 15, 2025
Jobma and Taleez Partner to Deliver Streamlined, Automated Hiring
EIN Presswire
·
May 15, 2025
Jobma and Taleez join forces to automate candidate screening by integrating AI video interviews, enabling robust hiring workflows. MINNETONKA, MN, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- Jobma, a leading AI hiring platform, has announced its …
Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update
GlobeNewswire
·
May 15, 2025
Conference call begins at 10:00 a.m. Eastern time on Friday, May 16, 2025 WOBURN, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic …
Shuttle Pharma Provides Corporate Update
GlobeNewswire
·
May 15, 2025
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
SkinPros: Receives 2025 ThreeBestRated® Award for Leading the Way in Skin Health and Cancer Prevention in Rhode Island
EIN Presswire
·
May 15, 2025
PROVIDENCE, RI, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- SkinPros is proud to announce that it has been honored with the 2025 ThreeBestRated® Award for excellence in dermatology. Founded by Antonio P. Cruz, M.D., FAAD, FACMS, FASLMS, in 2010, …
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
GlobeNewswire
·
May 15, 2025
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand. Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a …
Precision Optics Reports Third Quarter Fiscal Year 2025 Financial Results
GlobeNewswire
·
May 15, 2025
GARDNER, Mass., May 15, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an …
Globus Medical Announces $500 Million Share Repurchase Program
GlobeNewswire
·
May 15, 2025
AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s …
SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for …
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
GlobeNewswire
·
May 15, 2025
Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and distribution model Management to Host …
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
GlobeNewswire
·
May 15, 2025
ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and reported financial …
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025
GlobeNewswire
·
May 15, 2025
BASEL, Switzerland and LONDON and NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 29, 2025, to report its financial results for the …
Range Impact Reports 1Q 2025 Financial Results
GlobeNewswire
·
May 15, 2025
Cleveland, Ohio, May 15, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for the …
Solid Biosciences Reports First Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
May 15, 2025
- Duchenne (SGT-003): Participant dosing ongoing in the Phase 1/2 INSPIRE DUCHENNE trial; Solid on track to discuss accelerated pathways with U.S. FDA later in 2025 - - FA (SGT-212): Dosing of first participant anticipated in the second half of 2025 - - …
Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025
GlobeNewswire
·
May 15, 2025
New Analysis Shows Treatment with Investigational Paltusotine Resulted in Rapid and Durable IGF-1 Control in Surgically Naïve Acromegaly Patients Additional Research Includes Acromegaly Symptom Burden and Standard-of-Care Discontinuation Rates SAN DIEGO, …
SRx Health Solutions Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 15, 2025
EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health …
Septerna Highlights Business Progress and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 15, 2025
Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral Small Molecule PTH1R Agonist to Accelerate Toward the …
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
May 15, 2025
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected to enter IND-enabling studies in mid …
Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2025 and Provides Corporate Update
GlobeNewswire
·
May 15, 2025
LYTENAVA™ (bevacizumab gamma) on track for planned first commercial launches in Germany and the United Kingdom (UK) in Q2 CY2025 Prescription Drug User Fee Act (PDUFA) goal date of August 27, 2025 in the United States ISELIN, N.J., May 15, 2025 (GLOBE …
Physician Reveals Concerning Trend in Health Care Pricing and What Can Be Done About It
EIN Presswire
·
May 15, 2025
LA, UNITED STATES, May 15, 2025 /EINPresswire.com/ -- Surveys show most doctors are increasingly concerned about a trend in health care pricing; patients being charged more for the same service, depending on where they go. And most don’t even know it’s …
Best SARMs For Sale: Buy Legal SARMs For Bodybuilding & Cutting Cycles - Crazybulk
GlobeNewswire
·
May 15, 2025
New York City, NY, May 15, 2025 (GLOBE NEWSWIRE) -- Introduction In today’s fitness landscape, many are seeking faster, safer paths to noticeable physique changes. Whether it's for trimming body fat or sculpting lean muscle, SARMs—short for Selective …